GEDEON RICHTER |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.85 USD | +4.85% |
|
-.--% | +4.85% |
| 31/05 | Gedeon Richter Plc. Approves Dividend Payment in Respect of the 2023 Financial Year | CI |
| 22/05 | Gedeon Richter plc announces Directorate Changes | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Its low valuation, with P/E ratio at 7.17 and 6.54 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Ratings chart - Surperformance
Sector: Pharmaceuticals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +4.85% | 467.77Cr | - | ||
| +20.78% | 4.33TCr | B- | ||
| +27.64% | 2.24TCr | B+ | ||
| +18.88% | 1.55TCr | - | ||
| +18.68% | 1.45TCr | B+ | ||
| +54.64% | 1.29TCr | B | ||
| -0.05% | 678.76Cr | - | - | |
| -11.39% | 655.78Cr | B+ | ||
| +17.73% | 587.1Cr | B+ | ||
| -8.87% | 572.55Cr | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- RICHTER Stock
- GEDSF Stock
- Ratings Gedeon Richter
